Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment
Clinical trial NCT03615066 · COMPLETED
Trial details
- NCT number
- NCT03615066
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-28
- Primary completion
- 2019-12-12
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.